Product image of Vpriv (Velaglucerase Alfa) supplied by GNH India

Vpriv

Active Ingredient:
Velaglucerase Alfa
Origin:
EU

Vpriv (Velaglucerase Alfa)

Vpriv (Velaglucerase Alfa) is an enzyme replacement therapy for treating type 1 Gaucher disease. This intravenous medication helps manage symptoms by replacing a missing enzyme. It is prescribed under medical supervision for long-term use. Suitable for patients seeking enzyme therapy options.

Manufacturer / TM Owner

Takeda Pharmaceuticals International Ag Ireland Branch

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Velaglucerase Alfa is used to treat type 1 Gaucher disease, a rare genetic disorder affecting the body's ability to break down certain fats. It works by replacing the missing enzyme glucocerebrosidase, which helps reduce symptoms like enlarged organs and bone pain. This medication is intended for patients who require enzyme replacement therapy as part of their treatment plan.

Side Effects

  • Velaglucerase Alfa helps manage symptoms associated with Gaucher disease by improving the body's ability to process fats. Patients may experience reduced organ enlargement and improved energy levels over time. Regular administration is necessary to maintain its effects. Individual responses may vary based on medical condition.

Precautions & Warnings

  • This medication should only be administered under the supervision of a healthcare professional. Patients should inform their doctor about any allergies or medical conditions before starting treatment. Regular monitoring may be required to assess the medication's effectiveness and safety. It is important to follow the prescribed dosing schedule.

Avoid Interactions

  • Velaglucerase Alfa may interact with other medications, though specific interactions are not widely documented. Patients should inform their healthcare provider about all prescription, over-the-counter, and herbal products they are using. Caution is advised when combining with other therapies for Gaucher disease. Always consult a doctor before making changes to your treatment plan.

Frequently Asked Questions

Velaglucerase Alfa is used to treat type 1 Gaucher disease by replacing a missing enzyme.

It is given as an intravenous infusion under medical supervision.

It is specifically approved for type 1 Gaucher disease and not for other conditions.

Common side effects may include infusion reactions, headache, or nausea.

Availability depends on local regulations and prescription requirements.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated:

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Velaglucerase Alfa

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT